Lead Story: Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder

Lead Story: Association Between Buprenorphine Treatment Gaps, Opioid Overdose, and Health Care Spending in US Medicare Beneficiaries With Opioid Use Disorder

What happens when patients with opioid use disorder experience gaps in their buprenorphine treatment? This episode of 'Addiction Medicine Unpacked' from ASAM tackles this pressing question through an in-depth look at recent research studies. Claire Rasmussen presents findings that show a clear link between treatment gaps and increased risks of opioid overdose, along with higher healthcare costs for Medicare beneficiaries. This isn't just about numbers; it's about real lives affected by treatment adherence. The episode doesn't stop there.

It also explores the occurrence of psychotic symptoms in cannabis users, revealing that one in four people may experience acute, self-limiting psychosis at some point. Then, there's a focus on perinatal care for those receiving opiate agonist therapy, emphasizing the importance of self-advocacy for new mothers navigating complex healthcare systems. Another study discussed in the episode highlights the critical steps needed when initiating buprenorphine in an era dominated by high-potency synthetic opioids.

It underscores the necessity of detailed assessments regarding substance use and withdrawal severity. Finally, the episode sheds light on stimulant misuse among youth, noting that while prescription stimulants are most commonly misused, cocaine and methamphetamine use are also on the rise. If you're looking for a comprehensive overview of current challenges and solutions in addiction medicine, this episode is a must-listen.